ÇABALAK, M. Et Al. 2023. Real-life Data of Glecaprevir/Pibrentasvir in Chronic Hepatitis C Patients: A Single-center Study. Hepatitis Monthly , vol.23, no.1 .

ÇABALAK, M., Bal, T., OCAK, S., Bal, İ. A., & ÖNLEN, Y., (2023). Real-life Data of Glecaprevir/Pibrentasvir in Chronic Hepatitis C Patients: A Single-center Study. Hepatitis Monthly , vol.23, no.1.

ÇABALAK, MEHMET Et Al. "Real-life Data of Glecaprevir/Pibrentasvir in Chronic Hepatitis C Patients: A Single-center Study," Hepatitis Monthly , vol.23, no.1, 2023

ÇABALAK, MEHMET Et Al. "Real-life Data of Glecaprevir/Pibrentasvir in Chronic Hepatitis C Patients: A Single-center Study." Hepatitis Monthly , vol.23, no.1, 2023

ÇABALAK, M. Et Al. (2023) . "Real-life Data of Glecaprevir/Pibrentasvir in Chronic Hepatitis C Patients: A Single-center Study." Hepatitis Monthly , vol.23, no.1.

@article{article, author={MEHMET ÇABALAK Et Al. }, title={Real-life Data of Glecaprevir/Pibrentasvir in Chronic Hepatitis C Patients: A Single-center Study}, journal={Hepatitis Monthly}, year=2023}